error

Blockpass Heralds Cutting Edge Compliance Automation – Advanced KYC Bot(TM)

Source Node:
Time Stamp: January 23, 2024 4:57 AM - Modified On: January 23, 2024 - Published By:
Source Cluster:
Republished By Plato

HONG KONG, Jan 18, 2024 - (ACN Newswire) - Blockpass is proud to reveal a brand-new automation advancement that will see the KYC experience for its customers improved even further with the introduction of the Advanced KYC Bot(TM). Included as standard for all Managed Service add-on clients, the handy new bot will automate the KYC process even further, reducing the time and effort required for compliance by monitoring and processing flags to KYC profiles. Also available on a standalone basis for Enterprise customers, the Advanced KYC Bot(TM) builds on the capability

HealthCare AI: The Unavoidable Revolution in Modern Medicine

Source Node:
Time Stamp: October 5, 2023 3:39 PM - Modified On: October 5, 2023 - Published By:
Source Cluster:
Republished By Plato

By Eric Greenberg www.linkedin.com/in/ericabg In the evolving landscape of medical technology, there's one force that stands head and shoulders above the rest, promising a seismic shift in the very ethos of healthcare delivery: Artificial Intelligence (AI). As a seasoned technology and banking analyst, it is my considered opinion that Healthcare AI isn't just a trend or a buzzword. It’s the very future of medicine, poised to reshape everything we know about patient care, disease diagnosis, and medical research. To begin with, the economic implications of integrating AI in healthcare are

My Health Manifesto : Cracking The Code : Flying Solo

Source Node:
Time Stamp: September 11, 2023 12:37 PM - Modified On: September 11, 2023 - Published By:
Source Cluster:
Republished By Plato

Today when I Google "how long can a person live with my GFR 5% / kidney function the answer was "a few hours to a few weeks without dialysis." In a study with 8000+ patients 65+ with similar numbers; a month was the survival time. @68 (Stage 5 kidney failure is less than 15% /GFR; I'm not even anywhere on/near the chart) As I enter my Fourteenth/14th month; I am Defiantly hopeful. positive and optimistic that My Miracle will continue. #notmytimetodie #superoutlier While I challenge this death sentence I feel better and clearer

Verseon Acquires Edammo to Deepen Drug Discovery Approach

Source Node:
Time Stamp: November 13, 2022 3:46 AM - Modified On: November 17, 2022 - Published By:
Source Cluster:
Republished By Plato

Published: Nov 12th, 2022 | By Mark Terry Verseon Corporation has acquired Edammo, an artificial intelligence-focused company, to deepen its own AI-based drug discovery platform, the companies revealed Tuesday. Adityo Prakash, co-founder and CEO of Verseon and Ed Ratner, CEO at Edammo, discussed the acquisition with BioSpace. “We develop completely new drugs on the computer, atom by atom, then we make them in the laboratory,” Prakash said. "We’re changing how small molecule drugs are designed and developed with a level of efficiency that hasn’t been possible before.” He added that